Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.

Saved in:
Bibliographic Details
Title: Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.
Authors: Sim GC; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Box 904, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Chacon J, Haymaker C, Ritthipichai K, Singh M, Hwu P, Radvanyi L
Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2014 Oct; Vol. 28 (5), pp. 421-37.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-190X
DOI:10.1007/s40259-014-0097-y